cbdMD (YCBD) FCF Margin % : 5.60% (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is cbdMD FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. cbdMD's Free Cash Flow for the three months ended in Jun. 2024 was $0.29 Mil. cbdMD's Revenue for the three months ended in Jun. 2024 was $5.17 Mil. Therefore, cbdMD's FCF Margin % for the quarter that ended in Jun. 2024 was 5.60%.

As of today, cbdMD's current FCF Yield % is -62.01%.

The historical rank and industry rank for cbdMD's FCF Margin % or its related term are showing as below:

YCBD' s FCF Margin % Range Over the Past 10 Years
Min: -1297.82 Med: -48.24 Max: -5.25
Current: -5.25

During the past 9 years, the highest FCF Margin % of cbdMD was -5.25%. The lowest was -1297.82%. And the median was -48.24%.

YCBD's FCF Margin % is ranked worse than
66.06% of 993 companies
in the Drug Manufacturers industry
Industry Median: 0.89 vs YCBD: -5.25

cbdMD FCF Margin % Historical Data

The historical data trend for cbdMD's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

cbdMD FCF Margin % Chart

cbdMD Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

FCF Margin %

Get a 7-Day Free Trial

-70.29

-28.61

-36.95

-44.22

-19.04

cbdMD Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
FCF Margin %	Get a 7-Day Free Trial															-5.61	-6.72	-5.41	-15.97	5.60

Competitive Comparison of cbdMD's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

cbdMD's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's FCF Margin % distribution charts can be found below:

* The bar in red indicates where cbdMD's FCF Margin % falls into.

cbdMD FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

cbdMD's FCF Margin for the fiscal year that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Sep. 2023 )	/	Revenue (A: Sep. 2023 )
	=	-4.6	/	24.155
	=	-19.04 %

cbdMD's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	0.29	/	5.174
	=	5.60 %

cbdMD FCF Margin % Related Terms

Thank you for viewing the detailed overview of cbdMD's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

cbdMD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » cbdMD Inc (AMEX:YCBD) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

YCBDPA.PFD:USA

Address

8845 Red Oak Boulevard, Charlotte, NC, USA, 28217

Website

https://www.cbdmd.com

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Executives

Thomas Ronan Kennedy	officer: Interim CEO and CFO	8845 RED OAK BLVD, CHARLOTTE NC 28217
Bakari T. Sellers	director	4231 VOORHEES ROAD, DENMARK SC 29042
Raines William F Iii	director	8314 TOSOMOCK LANE, HUNTERSVILLE NC 28078
Scott G. Stephen	director	4249 NORTH WINCHESTER AVE., CHICAGO IL 60613
Sibyl Nichole Swift	director	730 HAWTHORNE LANE, APT 441, CHARLOTTE NC 28204
Kevin Macdermott	officer: President	9580 CALDWELL RD, MOUNT ULLA NC 28125
Wiesehan John J Iii	officer: Chief Revenue Officer	8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Sim Farar	director	8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Martin A. Sumichrast	director, officer: Chairman of the Board and CEO	11125 COLONIAL COUNTRY LANE, CHARLOTTE NC 28277
Raymond Scott Coffman	director	230 S. TRYON ST., #1302, CHARLOTTE NC 28202
Peter J. Ghiloni	director	115 DEER ESTATES LANE, PONTE VEDRA BEACH FL 32082
Mark S Elliott	officer: CFO & COO	C/O LEVEL BRANDS, INC., 4521 SHARON ROAD, SUITE 450, CHARLOTTE NC 28211
Gregory C Morris	director	421 CRANBORNE CHASE, FORT MILL SC 29708
Caryn Nicole Dunayer	officer: President	8476 CATAWBA DOVE DR., BELMONT NC 28012
Erik Sterling	10 percent owner	5505 KALANIANAOLE HWY, HONOLULU HI 96821